Credit By: SciTechDaily
Your brain can create its cannabinoids in response to stressful events; these compounds have a calming effect by activating the same brain receptors as THC in cannabis plants. It is unknown, nonetheless, what neuronal patterns and mechanisms underlie these endogenous cannabinoids. According to a recent Northwestern Medicine study on mice, stress causes the brain’s primary emotional region, the amygdala, to release endogenous cannabinoids. The hippocampus, a brain region that controls memory and emotion, then triggers the stress response, which these chemicals aid in reducing. This research implies that these endogenous cannabinoids function as a built-in stress management system.
The Connection Between Mental Health and Stress
Stress exposure raises the possibility of psychiatric disorders such as major depressive disorder, PTSD, and generalized anxiety disorder occurring or worsening. To understand how stress might cause mood disorders, it is important to understand how the brain adjusts to stress at the molecular, cellular, and circuit level. This understanding may also provide new therapeutic targets for treating stress-related diseases.
Consequences for Disorders Associated with Stress
The study suggests that people may be more prone to stress-related mental illnesses like depression and PTSD if they have abnormalities in their endogenous cannabinoid signalling system. In humans, this relationship has not yet been verified.
Approach and Results Analysis
The presence of these endogenous cannabis compounds at certain brain synapses was detected in real-time by the researchers using a new protein sensor. They discovered that specific high-frequency patterns of amygdala activity can trigger the release of these chemicals. Mice under various forms of stress also released these cannabinoids.
When the researchers eliminated the cannabinoid receptor type 1 target, the mice developed poor stress-coping skills and motivation deficiencies. Particularly, after exposure to stress, mice lacking these receptors showed passive and immobile reactions and a decreased preference for sweetened sucrose water. This may be related to anhedonia, a decreased pleasure frequently observed in patients suffering from stress-related conditions like depression and PTSD.
The Therapeutic Potential of Endogenous Cannabinoids
The endocannabinoid system is one of the most promising signalling pathways for creating medications to treat stress-related psychiatric diseases. The next obvious step is to ascertain whether raising endogenous cannabinoid levels may be utilized as possible therapies for these illnesses; clinical trials are now being conducted in this area and may yield answers soon.
Our research illuminates the intriguing relationship between stress, endogenous cannabinoids in the brain, and their function in modulating the stress response. Understanding these pathways may make novel strategies for treating stress-related mental health issues possible.
Follow ARP Media for more health related content.